Observation of genotype C infected chronic hepatitis B patients in clinical practice

Journal of Infection in Developing Countries

Volumn 5, Issue 12, 2011, Pages 882-889

  Aung, Myo Nyein ^a,b,c   Leowattana, Wattana ^a   Tangpukdee, Noppadon ^a   Kittitrakul, Chatporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b University of Public Health   (Myanmar)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis B; Genotype C hepatitis B; Thailand

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TELBIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; CHINA; CLINICAL ARTICLE; CLINICAL PRACTICE; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; MALE; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE; VIRUS LOAD;

EID: 83755186376     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1480     Document Type: Article

References (28)

1. World Health Organization. Hepatitis B.: World Health Organization (2008) [updated August 2008 cited 2008 4 December 2009]; Available from: http://www.who.int/mediacentre/factsheets/fs204/en/.
2. Kew MC (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol 6: 6.
3. Tangkijvanich P, Mahachai V, Komolmit P, Fongsarun J, Theamboonlers A, Poovorawan Y (2005) Hepatitis B virus genotypes and hepatocellular carcinoma in Thailand. World J Gastroenterol 11: 2238-2243.
4. Chan HL-Y, Hui AY, Wong ML, Tse AM-L, Hung LC-T, Wong VW-S, Sung JJ-Y (2004) Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 5: 1494-1498.
5. Yang H-I, Lu S-N, Liaw Y-F, You S-L, Sun C-A, Wang L-Y, Hsiao CK, Chen P-J, Chen D-S, Chen C-J, the Taiwan Community-Based Cancer Screening Project Group (2002) Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma. N Engl J Med 347: 168-174.
6. Chen C-J, Yang H-I, Su J, Jen C-L, You S-L, Lu S-N, Huang G-T, Iloeje UH, for the REVEAL-HBV Study Group (2006) Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level. JAMA 295: 65-73.
7. Iloeje UH, Yang H-I, Su J, Jen C-L, You S-L, Chen C-J (2006) Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load. Gastroenterol 130: 678-686.
8. Miyakawa Y and Mizokami M (2003) Classifying Hepatitis B Virus Genotypes. Intervirol 46: 329-338.
9. Suwannakarn K, Tangkijvanich P, Thawornsuk N, Theamboonlers A, Tharmaphornpilas P, Yoocharoen P, Chongsrisawat V, Poovorawan Y (2008) Molecular epidemiological study of hepatitis B virus in Thailand based on the analysis of pre-S and S genes. Hepatol Res 38: 244-251.
10. Sa-nguanmoo P, Tangkijvanich P, Thawornsuk N, Vichaiwattana P, Prianantathavorn K, Theamboonlers A, Tanaka Y, Poovorawan Y. (2010) Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand. J Med Virol 82: 1341-1349.
11. Liaw YF (2009) Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia. J Hepatol 51: 403-410.
12. Sugauchi F, Chutaputti A, Orito E, Kato H, Suzuki S, Ueda R, Mizokami M (2002) Hepatitis B virus genotypes and clinical manifestation among hepatitis B carriers in Thailand. J Gastroenterol Hepatol 17: 671-676.
13. Chun Tao Wai, Chi-Jen Chu, Munira Hussain, Anna S. F. Lok (2002) HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. J Hepatol 36: 1425-30.
14. Kao J-H, Wu N-H, Chen P-J, Lai M-Y, Chen D-S (2000) Hepatitis B genotypes and the response to interferon therapy. J Hepatol 33: 998-1002.
15. Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW (2007) Genotype B and younger patient age associated with better response to low-dose therapy: A trial with pegylated/nonpegylated interferon-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. Clin Infect Dis 44: 541-548.
16. Chainuvati S, Cheng J, Hou J, Hsu C, Jia J, Komolmit P, Kwon S, Lee C, Li H, Li Y, Liu C, Neo B, Peng C, Tanwandee T, Wongcharatrawee S, Wu J, Yu M, Zhang X (2009) Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand. Hepatol Int 3: 453-460.
17. Pas SD, Tran N, de Man RA, Burghoorn-Maas C, Vernet G, Niesters HG (2008) Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virus. J Clin Microbiol 46: 1268-1273.
18. Raimondi S, Maisonneuve P, Bruno S, Mondelli MU (2010) Is response to antiviral treatment influenced by hepatitis B virus genotype? J Hepatol 52: 441-449.
19. Chien R-N, Yeh C-T, Tsai S-L, Chu C-M, Liaw Y-F (2003) Determinants for sustained HBeAg response to lamivudine therapy. Hepatol 38: 1267-1273.
20. Zeng A-Z, Deng H, Yang C, Xin X-J, Li Q-L, Guo J-J, Lu P, Huang A-L (2008) Hepatitis B Virus Genotype-Associated Variability in Antiviral Response to Adefovir Dipivoxil Therapy in Chinese Han Population. J Tohoku Exp Med 216: 205-211.
21. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV (2004) Global Epidemiology of Hepatitis B Virus. Clin Gastroenterol 38: S158-S168.
22. Maeshiro T, Arakaki S, Watanabe T, Aoyama H, Shiroma J, Yamashiro T, Hirata T, Hokama A, Kinjo F, Nakayoshi T, Mizokami M, Fujita J, Sakugawa H (2007) Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life. World J Gastroenterol 13: 4560-4565.
23. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S (2008) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2: 263-283.
24. Lok ASF, McMahon BJ (2007) Corrections to AASLD guidelines on chronic hepatitis B. J Hepatol 45: 1347.
25. European Association for the Study of the L (2009) EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 50: 227-42.
26. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H (2008) A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol 6: 1315-1341.
27. Westland C, Delaney W, Yang H, Chen S-S, Marcellin P, Hadziyannis S, Gish R, Fry J, Brosgart C, Gibbs C, Miller M, Xiong S (2003) Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil. J Gastroenterol 125: 107-116.
28. Sung JJ, Tsoi KK, Wong VW, Li KC, Chan HL (2008) Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther 28: 1067-1077.